CD274 and neoplasm: The prognostic performance of pre-S2 mutant, intra-tumoral PD-L1 expression, tumor-infiltrating Tregs, and a combination of either two or all of these three biomarkers for HCC recurrence after curative surgical resection was evaluated by ROC curves.